Salvage Therapy With Thalidomide In Patients With Advanced Relapsed/Refractory Multiple Myeloma
P. Tosi(Orthopaedic Research Foundation), Michèle Cavo(Unknown), Angelo Vacca(University of Bari Aldo Moro), Roberto Ria(University of Bari Aldo Moro), Filippo Ballerini(Ospedale Policlinico San Martino), Sonia Ronconi(Istituti di Ricovero e Cura a Carattere Scientifico), Claudia Cellini(Ospedale Santa Maria), Francesco Di Raimondo(University of Catania), Michele Baccarani(University of Bologna), Elena Zamagni(Istituti di Ricovero e Cura a Carattere Scientifico), Francesca Patriarca(Ospedale Santa Maria della Misericordia di Udine), Marco Gobbi(Istituto di Ematologia di Bologna), P. Musto(University of Indianapolis), A Ledda(University of Bologna), Francesco Lauria(Ospedale Santa Maria alle Scotte), Luciano Masini(Casa di Cura Villa Garda), S Tura(University of Bologna), Delia Cangini(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori)
Cited by 10
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
|Leukemia|2008|808
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
|Leukemia|2011|721
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719